Of mice without pockets: Mouse models to study the function of RB family proteins

Frontiers in Bioscience

Volumn 12, Issue 12, 2007, Pages 4483-4496

  Vidal, Anxo ^a   Carneiro, Carmen ^a   Zalvide, Juan B ^a  

^a UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

Author keywords

Cancer; Cell cycle; Mouse model; Neoplasia; Pocket proteins; Review; Tumor

Indexed keywords

MUS;

RETINOBLASTOMA PROTEIN;

ANIMAL; ANIMAL MODEL; GENETICS; MOUSE; MOUSE MUTANT; PHYSIOLOGY; REVIEW;

ANIMALS; MICE; MICE, KNOCKOUT; MODELS, ANIMAL; RETINOBLASTOMA PROTEIN;

EID: 34347207181     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: 10.2741/2403     Document Type: Review

References (155)

1. S. H. Friend, R. Bernards, S. Rogelj, R. A. Weinberg, J. M. Rapaport, D. M. Albert, and T. P. Dryja: A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma. Nature 323, 643-646 (1986) (Pubitemid 16008560)
2. W. H. Lee, R. Bookstein, F. Hong, L. J. Young, J. Y. Shew, and E. Y. Lee: Human retinoblastoma susceptibility gene: cloning, identification, and sequence. Science 235, 1394-1399 (1987) (Pubitemid 17041661)
3. J. W. Harbour, S. L. Lai, J. Whang-Peng, A. F. Gazdar, J. D. Minna, and F. J. Kaye: Abnormalities in structure and expression of the human retinoblastoma gene in SCLC. Science 241, 353-357 (1988)
4. J. M. Horowitz, D. W. Yandell, S. H. Park, S. Canning, P. Whyte, K. Buchkovich, E. Harlow, R. A. Weinberg, and T. P. Dryja: Point mutational inactivation of the retinoblastoma antioncogene. Science 243, 937-940 (1989) (Pubitemid 19066154)
5. E. Y. Lee, H. To, J. Y. Shew, R. Bookstein, P. Scully, and W. H. Lee: Inactivation of the retinoblastoma susceptibility gene in human breast cancers. Science 241, 218-221 (1988)
6. D. Cobrinik, P. Whyte, D. S. Peeper, T. Jacks, and R. A. Weinberg: Cell cycle-specific association of E2F with the p130 E1A-binding protein. Genes Dev. 7, 2392-2404 (1993) (Pubitemid 24003242)
7. M. E. Ewen, Y. G. Xing, J. B. Lawrence, and D. M. Livingston: Molecular cloning, chromosomal mapping, and expression of the cDNA for p107, a retinoblastoma gene product-related protein. Cell 66, 1155-1164 (1991) (Pubitemid 121001405)
8. G. J. Hannon, D. Demetrick, and D. Beach: Isolation of the Rb-related p130 through its interaction with CDK2 and cyclins. Genes Dev. 7, 2378-2391 (1993) (Pubitemid 24003241)
9. X. Mayol, X. Grana, A. Baldi, N. Sang, Q. Hu, and A. Giordano: Cloning of a new member of the retinoblastoma gene family (pRb2) which binds to the E1A transforming domain. Oncogene 8, 2561-2566 (1993) (Pubitemid 23252387)
10. D. Cobrinik: Pocket proteins and cell cycle control. Oncogene 24, 2796-2809 (2005) (Pubitemid 40638091)
11. M. V. Frolov and N. J. Dyson: Molecular mechanisms of E2F-dependent activation and pRB-mediated repression. J. Cell Sci. 117, 2173-2181 (2004) (Pubitemid 38807486)
12. O. Stevaux and N. J. Dyson: A revised picture of the E2F transcriptional network and RB function. Curr. Opin. Cell Biol. 14, 684-691 (2002) (Pubitemid 35449380)
13. D. K. Dimova and N. J. Dyson: The E2F transcriptional network: old acquaintances with new faces. Oncogene 24, 2810-2826 (2005) (Pubitemid 40638092)
14. J. Christensen, P. Cloos, U. Toftegaard, D. Klinkenberg, A. P. Bracken, E. Trinh, M. Heeran, L. Di Stefano, and K. Helin: Characterization of E2F8, a novel E2F-like cell-cycle regulated repressor of E2F-activated transcription. Nucleic Acids Research 33, 5458-5470 (2005) (Pubitemid 41548812)
15. N. Logan, A. Graham, X. J. Zhao, R. Fisher, B. Maiti, G. Leone, and N. B. La Thangue: E2F-8: an E2F family member with a similar organization of DNA-binding domains to E2F-7. Oncogene 24, 5000-5004 (2005) (Pubitemid 41129104)
16. B. Maiti, J. Li, A. de Bruin, F. Gordon, C. Timmers, R. Opavsky, K. Patil, J. Tuttle, W. Cleghorn, and G. Leone: Cloning and characterization of mouse E2F8, a novel mammalian E2F family member capable of blocking cellular proliferatio. Journal of Biological Chemistry 280, 18211-18220 (2005) (Pubitemid 41389066)
17. H. Cam and B. D. Dynlacht: Emerging roles for E2F: beyond the G1/S transition and DNA replication. Cancer Cell 3, 311-316 (2003) (Pubitemid 38340300)
18. A. Blais and B. D. Dynlacht: Hitting their targets: an emerging picture of E2F and cell cycle control. Curr. Opin. Genet. Dev. 14, 527-532 (2004) (Pubitemid 39360300)
19. Y. Dai, T. E. Hamm, P. Dent, and S. Grant: Cyclin d1 overexpression increases the susceptibility of human u266 myeloma cells to CDK inhibitors through a process involving p130-, p107-and E2F-dependent S phase entry. Cell Cycle 5, 437-446 (2006)
20. K. Hansen, T. Farkas, J. Lukas, K. Holm, L. Ronnstrand, and J. Bartek: Phosphorylation-dependent and-independent functions of p130 cooperate to evoke a sustained G (1) block. EMBO J. 20, 422-432 (2001) (Pubitemid 32126978)
21. E. Y. Lee, H. Cam, U. Ziebold, J. B. Rayman, J. A. Lees, and B. D. Dynlacht: E2F4 loss suppresses tumorigenesis in Rb mutant mice. Cancer Cell 2, 463-472 (2002) (Pubitemid 41043951)
22. E. K. Flemington, S. H. Speck, and W. G. Kaelin, Jr.: E2F-1-mediated transactivation is inhibited by complex formation with the retinoblastoma susceptibility gene product. Proc. Natl. Acad. Sci. U. S. A 90, 6914-6918 (1993) (Pubitemid 23222358)
23. K. Helin, E. Harlow, and A. Fattaey: Inhibition of E2F-1 transactivation by direct binding of the retinoblastoma protein. Mol. Cell Biol. 13, 6501-6508 (1993) (Pubitemid 23292644)
24. R. Ferreira, L. Magnaghi-Jaulin, P. Robin, A. Harel-Bellan, and D. Trouche: The three members of the pocket proteins family share the ability to repress E2F activity through recruitment of a histone deacetylase. Proc. Natl. Acad. Sci. U. S. A 95, 10493-10498 (1998) (Pubitemid 28413095)
25. R. X. Luo, A. A. Postigo, and D. C. Dean: Rb interacts with histone deacetylase to repress transcription. Cell 92, 463-473 (1998) (Pubitemid 28101110)
26. P. Stiegler, L. A. De, L. Bagella, and A. Giordano: The COOH-terminal region of pRb2/p130 binds to histone deacetylase 1 (HDAC1), enhancing transcriptional repression of the E2F-dependent cyclin A promoter. Cancer Res. 58, 5049-5052 (1998) (Pubitemid 28521158)
27. S. J. Nielsen, R. Schneider, U. M. Bauer, A. J. Bannister, A. Morrison, D. O'Carroll, R. Firestein, M. Cleary, T. Jenuwein, R. E. Herrera, and T. Kouzarides: Rb targets histone H3 methylation and HP1 to promoters. Nature 412, 561-565 (2001) (Pubitemid 32743837)
28. H. Ogawa, K. Ishiguro, S. Gaubatz, D. M. Livingston, and Y. Nakatani: A complex with chromatin modifiers that occupies E2F-and Myc-responsive genes in G (0) cells. Science 296, 1132-1136 (2002) (Pubitemid 34517133)
29. J. F. Ross, X. Liu, and B. D. Dynlacht: Mechanism of transcriptional repression of E2F by the retinoblastoma tumor suppressor protein. Mol. Cell 3, 195-205 (1999) (Pubitemid 29292620)
30. J. L. Dunaief, B. E. Strober, S. Guha, P. A. Khavari, K. Alin, J. Luban, M. Begemann, G. R. Crabtree, and S. P. Goff: The retinoblastoma protein and BRG1 form a complex and cooperate to induce cell cycle arrest. Cell 79, 119-130 (1994) (Pubitemid 24309518)
31. B. E. Strober, J. L. Dunaief, Guha, and S. P. Goff: Functional interactions between the hBRM/hBRG1 transcriptional activators and the pRB family of proteins. Mol. Cell Biol. 16, 1576-1583 (1996) (Pubitemid 26095629)
32. P. D. Adams: Regulation of the retinoblastoma tumor suppressor protein by cyclin/cdks. Biochim. Biophys. Acta 1471, M123-M133 (2001) (Pubitemid 32206688)
33. J. Calbo, M. Parreno, E. Sotillo, T. Yong, A. Mazo, J. Garriga, and X. Grana: G1 cyclin/cyclin-dependent kinasecoordinated phosphorylation of endogenous pocket proteins differentially regulates their interactions with E2F4 and E2F1 and gene expression. J. Biol. Chem. 277, 50263-50274 (2002) (Pubitemid 36042174)
34. M. E. Ewen, H. K. Sluss, C. J. Sherr, H. Matsushime, J. Kato, and D. M. Livingston: Functional interactions of the retinoblastoma protein with mammalian D-type cyclins. Cell 73, 487-497 (1993) (Pubitemid 23143348)
35. P. W. Hinds, S. Mittnacht, V. Dulic, A. Arnold, S. I. Reed, and R. A. Weinberg: Regulation of retinoblastoma protein functions by ectopic expression of human cyclins. Cell 70, 993-1006 (1992)
36. J. W. Harbour, R. X. Luo, S. A. Dei, A. A. Postigo, and D. C. Dean: Cdk phosphorylation triggers sequential intramolecular interactions that progressively block Rb functions as cells move through G1. Cell 98, 859-869 (1999) (Pubitemid 29446902)
37. S. M. Rubin, A. L. Gall, N. Zheng, and N. P. Pavletich: Structure of the Rb C-Terminal Domain Bound to E2F1-DP1: A Mechanism for Phosphorylation-Induced E2F Release. Cell 123, 1093-1106 (2005) (Pubitemid 41785423)
38. R. L. Beijersbergen, L. Carlee, R. M. Kerkhoven, and R. Bernards: Regulation of the retinoblastoma protein-related p107 by G1 cyclin complexes. Genes Dev. 9, 1340-1353 (1995)
39. S. Shirodkar, M. Ewen, J. A. DeCaprio, J. Morgan, D. M. Livingston, and T. Chittenden: The transcription factor E2F interacts with the retinoblastoma product and a p107-cyclin A complex in a cell cycle-regulated manner. Cell 68, 157-166 (1992)
40. Y. Takahashi, J. B. Rayman, and B. D. Dynlacht: Analysis of promoter binding by the E2F and pRB families in vivo: distinct E2F proteins mediate activation and repression. Genes Dev. 14, 804-816 (2000) (Pubitemid 30215000)
41. R. K. Hurford, D. Cobrinik, M. H. Lee, and N. Dyson: pRB and p107/p130 are required for the regulated expression of different sets of E2F responsive genes. Genes Dev. 11, 1447-1463 (1997) (Pubitemid 27259855)
42. E. P. Black, E. Huang, H. Dressman, R. Rempel, N. Laakso, S. L. Asa, S. Ishida, M. West, and J. R. Nevins: Distinct gene expression phenotypes of cells lacking Rb and Rb family members. Cancer Res. 63, 3716-3723 (2003) (Pubitemid 36793057)
43. J. Wells, K. E. Boyd, C. J. Fry, S. M. Bartley, and P. J. Farnham: Target gene specificity of E2F and pocket protein family members in living cells. Mol. Cell Biol. 20, 5797-5807 (2000) (Pubitemid 30613029)
44. E. Balciunaite, A. Spektor, N. H. Lents, H. Cam, R. H. te, A. Scime, M. A. Rudnicki, R. Young, and B. D. Dynlacht: Pocket protein complexes are recruited to distinct targets in quiescent and proliferating cells. Mol. Cell Biol. 25, 8166-8178 (2005) (Pubitemid 41263008)
45. A. J. Morrison, C. Sardet, and R. E. Herrera: Retinoblastoma protein transcriptional repression through histone deacetylation of a single nucleosome. Mol. Cell Biol. 22, 856-865 (2002) (Pubitemid 34053063)
46. M. Collado and M. Serrano: The power and the promise of oncogene-induced senescence markers. Nature Reviews Cancer 6, 472-476 (2006)
47. G. Ferbeyre, E. de Stanchina, A. W. Lin, E. Querido, M. E. McCurrach, G. J. Hannon, and S. W. Lowe: Oncogenic ras and p53 Cooperate To Induce Cellular Senescence. Mol. Cell Biol. 22, 3497-3508 (2002) (Pubitemid 34453988)
48. J. H. Dannenberg, A. van Rossum, L. Schuijff, and H. T. Riele: Ablation of the Retinoblastoma gene family deregulates G (1) control causing immortalization and increased cell turnover under growth-restricting conditions. Genes Dev. 14, 3051-3064 (2000)
49. J. Sage, G. J. Mulligan, L. D. Attardi, A. Miller, S. Q. Chen, B. Williams, E. Theodorou, and T. Jacks: Targeted disruption of the three Rb-related genes leads to loss of G (1) control and immortalization. Genes Dev. 14, 3037-3050 (2000)
50. M. Narita, S. Nunez, E. Heard, M. Narita, A. W. Lin, S. A. Hearn, D. L. Spector, G. J. Hannon, and S. W. Lowe: Rb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence. Cell 113, 703-716 (2003) (Pubitemid 36724935)
51. P. D. Adams, W. R. Sellers, S. K. Sharma, A. D. Wu, C. M. Nalin, and W. G. J. Kaelin: Identification of a cyclincdk2 recognition motif present in substrates and p21-like cyclin-dependent kinase inhibitors. Mol. Cell Biol. 16, 6623-6633 (1996) (Pubitemid 26389720)
52. E. Castano, Y. Kleyner, and B. D. Dynlacht: Dual cyclin-binding domains are required for p107 to function as a kinase inhibitor. Mol. Cell Biol. 18, 5380-5391 (1998) (Pubitemid 28388121)
53. L. Zhu, E. Harlow, and B. D. Dynlacht: p107 uses a p21CIP1-related domain to bind cyclin/cdk2 and regulate interactions with E2F. Genes Dev. 9, 1740-1752 (1995)
54. M. E. Ewen, B. Faha, E. Harlow, and D. M. Livingston: Interaction of p107 with cyclin A independent of complex formation with viral oncoproteins. Science 255, 85-87 (1992)
55. E. Lees, B. Faha, V. Dulic, S. I. Reed, and E. Harlow: Cyclin-e Cdk2 and Cyclin-A Cdk2 Kinases Associate with P107 and E2F in A Temporally Distinct Manner. Genes Dev. 6, 1874-1885 (1992)
56. S. Coats, P. Whyte, M. L. Fero, S. Lacy, G. Chung, E. Randel, E. Firpo, and J. M. Roberts: A new pathway for mitogen-dependent cdk2 regulation uncovered in p27 (Kip1)-deficient cells. Curr. Biol. 9, 163-173 (1999) (Pubitemid 29120380)
57. I. Soeiro, A. Mohamedali, H. M. Romanska, N. C. Lea, E. S. Child, J. Glassford, S. J. Orr, C. Roberts, K. N. Naresh, E. N. Lalani, D. J. Mann, R. J. Watson, N. S. B. Thomas, and E. W. F. Lam: p27 (Kip1) and p130 cooperate to regulate hematopoietic cell proliferation in vivo. Mol. Cell. Biol. 26, 6170-6184 (2006) (Pubitemid 44204535)
58. T. Chibazakura, S. G. McGrew, J. A. Cooper, H. Yoshikawa, and J. M. Roberts: Regulation of cyclin-dependent kinase activity during mitotic exit and maintenance of genome stability by p21, p27, and p107. Proc. Natl. Acad. Sci. U. S. A 101, 4465-4470 (2004) (Pubitemid 38437434)
59. A. Vidal, S. Zacharoulis, W. J. Guo, D. Shaffer, F. Giancotti, A. H. Bramley, C. de la Hoz, K. K. Jensen, D. Kato, D. D. MacDonald, J. Knowles, N. Yeh, L. A. Frohman, S. Rafii, D. Lyden, and A. Koff: P130 (Rb2) and p27 (kip1) cooperate to control mobilization of angiogenic progenitors from the bone marrow. Proc. Natl. Acad. Sci. U. S. A. 102, 6890-6895 (2005) (Pubitemid 40675412)
60. P. Ji, H. Jiang, K. Rekhtman, J. Bloom, M. Ichetovkin, M. Pagano, and L. Zhu: An Rb-Skp2-p27 Pathway Mediates Acute Cell Cycle Inhibition by Rb and Is Retained in a Partial-Penetrance Rb Mutant. Mol. Cell 16, 47-58 (2004) (Pubitemid 39330151)
61. G. Rodier, C. Makris, P. Coulombe, A. Scime, K. Nakayama, K. I. Nakayama, and S. Meloche: p107 inhibits G1 to S phase progression by down-regulating expression of the F-box protein Skp2. J. Cell Biol. 168, 55-66 (2005) (Pubitemid 40111057)
62. W. R. Sellers, B. G. Novitch, S. Miyake, A. Heith, G. A. Otterson, F. J. Kaye, A. B. Lassar, and W. G. J. Kaelin: Stable binding to E2F is not required for the retinoblastoma protein to activate transcription, promote differentiation, and suppress tumor cell growth. Genes Dev. 12, 95-106 (1998) (Pubitemid 28083661)
63. M. Classon, B. K. Kennedy, R. Mulloy, and E. Harlow: Opposing roles of pRB and p107 in adipocyte differentiation. Proc. Natl. Acad. Sci. U. S. A. 97, 10826-10831 (2000)
64. E. Batsche, J. Desroches, S. Bilodeau, Y. Gauthier, and J. Drouin: Rb enhances p160/SRC coactivator-dependent activity of nuclear receptors and hormone responsiveness. J. Biol. Chem. 280, 19746-19756 (2005) (Pubitemid 41379500)
65. E. Batsche, P. Moschopoulos, J. Desroches, S. Bilodeau, and J. Drouin: Retinoblastoma and the related pocket protein p107 act as coactivators of NeuroD1 to enhance gene transcription. J. Biol. Chem. 280, 16088-16095 (2005) (Pubitemid 40616733)
66. D. M. Thomas, S. A. Carty, D. M. Piscopo, J. S. Lee, W. F. Wang, W. C. Forrester, and P. W. Hinds: The retinoblastoma protein acts as a transcriptional coactivator required for osteogenic differentiation. Mol. Cell 8, 303-316 (2001) (Pubitemid 32831548)
67. E. V. Benevolenskaya, H. L. Murray, P. Branton, R. A. Young, and W. G. Kaelin, Jr.: Binding of pRB to the PHD protein RBP2 promotes cellular differentiation. Mol. Cell 18, 623-635 (2005) (Pubitemid 40804799)
68. S. Gagrica, S. Hauser, I. Kolfschoten, L. Osterloh, R. Agami, and S. Gaubatz: Inhibition of oncogenic transformation by mammalian Lin-9, a pRB-associated protein. EMBO J. 23, 4627-4638 (2004) (Pubitemid 39657862)
69. B. K. Kennedy, D. A. Barbie, M. Classon, N. Dyson, and E. Harlow: Nuclear organization of DNA replication in primary mammalian cells. Genes Dev. 14, 2855-2868 (2000)
70. G. Bosco, W. Du, and T. L. Orr-Weaver: DNA replication control through interaction of E2F-RB and the origin recognition complex. Nat. Cell Biol. 3, 289-295 (2001) (Pubitemid 32201324)
71. I. Royzman, A. Hayashi-Hagihara, K. J. Dej, G. Bosco, J. Y. Lee, and T. L. Orr-Weaver: The E2F cell cycle regulator is required for Drosophila nurse cell DNA replication and apoptosis. Mech. Dev. 119, 225-237 (2002) (Pubitemid 35430110)
72. E. S. Knudsen, C. Buckmaster, T. T. Chen, J. R. Feramisco, and J. Y. Wang: Inhibition of DNA synthesis by RB: effects on G1/S transition and S-phase progression. Genes Dev. 12, 2278-2292 (1998) (Pubitemid 28371349)
73. R. J. White, D. Trouche, K. Martin, S. P. Jackson, and T. Kouzarides: Repression of RNA polymerase III transcription by the retinoblastoma protein. Nature 382, 88-90 (1996) (Pubitemid 26243364)
74. M. Garcia-Cao, S. Gonzalo, D. Dean, and M. A. Blasco: A role for the Rb family of proteins in controlling telomere length. Nat. Genet. 32, 415-419 (2002) (Pubitemid 35266118)
75. S. Gonzalo, M. Garcia-Cao, M. F. Fraga, G. Schotta, A. H. Peters, S. E. Cotter, R. Eguia, D. C. Dean, M. Esteller, T. Jenuwein, and M. A. Blasco: Role of the RB1 family in stabilizing histone methylation at constitutive heterochromatin. Nat. Cell Biol. 7, 420-428 (2005) (Pubitemid 40533133)
76. A. R. Clarke, E. R. Maandag, M. Vanroon, N. M. T. Vanderlugt, M. Vandervalk, M. L. Hooper, A. Berns, and H. T. Riele: Requirement for A Functional Rb-1 Gene in Murine Development. Nature 359, 328-330 (1992)
77. T. Jacks, A. Fazeli, E. M. Schmitt, R. T. Bronson, M. A. Goodell, and R. A. Weinberg: Effects of An Rb Mutation in the Mouse. Nature 359, 295-300 (1992)
78. E. Y. H. P. Lee, C. Y. Chang, N. P. Hu, Y. C. J. Wang, C. C. Lai, K. Herrup, W. H. Lee, and A. Bradley: Mice Deficient for Rb Are Nonviable and Show Defects in Neurogenesis and Hematopoiesis. Nature 359, 288-294 (1992)
79. L. Z. Wu, A. de Bruin, H. I. Saavedra, M. Starovic, A. Trimboli, Y. Yang, J. Opavska, P. Wilson, J. C. Thompson, M. C. Ostrowski, T. J. Rosol, L. A. Woollett, M. Weinstein, J. C. Cross, M. L. Robinson, and G. Leone: Extra-embryonic function of Rb is essential for embryonic development and viability. Nature 421, 942-947 (2003) (Pubitemid 36288025)
80. D. Cobrinik, M. H. Lee, G. Hannon, G. Mulligan, R. T. Bronson, N. Dyson, E. Harlow, D. Beach, R. A. Weinberg, and T. Jacks: Shared role of the pRB-related p130 and p107 proteins in limb development. Genes Dev. 10, 1633-1644 (1996) (Pubitemid 26268868)
81. M. H. Lee, B. O. Williams, G. Mulligan, S. Mukai, R. T. Bronson, N. Dyson, E. Harlow, and T. Jacks: Targeted disruption of p107: Functional overlap between p107 and Rb. Genes Dev. 10, 1621-1632 (1996) (Pubitemid 26268867)
82. J. Sage, A. L. Miller, P. A. Perez-Mancera, J. M. Wysocki, and T. Jacks: Acute mutation of retinoblastoma gene function is sufficient for cell cycle re-entry. Nature 424, 223-228 (2003) (Pubitemid 36858693)
83. H. I. Saavedra, L. Z. Wu, A. de Bruin, C. Timmers, T. J. Rosol, M. Weinstein, M. L. Robinson, and G. Leone: Specificity of E2F1, E2F2, and E2F3 in mediating phenotypes induced by loss of Rb. Cell Growth & Differentiation 13, 215-225 (2002) (Pubitemid 34651182)
84. K. Y. Tsai, Y. W. Hu, K. F. Macleod, D. Crowley, L. Yamasaki, and T. Jacks: Mutation of E2f-1 suppresses apoptosis and inappropriate S phase entry and extends surival of Rb-deficient mouse embryos. Mol. Cell 2, 293-304 (1998) (Pubitemid 128379270)
85. U. Ziebold, E. Y. Lee, R. T. Bronson, and J. A. Lees: E2F3 loss has opposing effects on different pRB-deficient tumors, resulting in suppression of pituitary tumors but metastasis of medullary thyroid carcinomas. Mol. Cell Biol. 23, 6542-6552 (2003) (Pubitemid 37075765)
86. A. Lasorella, M. Noseda, M. Beyna, and A. Iavarone: Id2 is a retinoblastoma protein target and mediates signalling by Myc oncoproteins. Nature 407, 592-598 (2000)
87. A. Iavarone, P. Garg, A. Lasorella, J. Hsu, and M. A. Israel: The helix-loop-helix protein Id-2 enhances cell proliferation and binds to the retinoblastoma protein. Genes Dev. 8, 1270-1284 (1994)
88. S. Marino, M. Vooijs, H. van der Gulden, J. Jonkers, and A. Berns: Induction of medulloblastomas in p53-null mutant mice by somatic inactivation of Rb in the external granular layer cells of the cerebellum. Genes Dev. 4, 994-1004 (2000) (Pubitemid 30253007)
89. D. MacPherson, J. Sage, D. Crowley, A. Trumpp, R. T. Bronson, and T. Jacks: Conditional mutation of Rb causes cell cycle defects without apoptosis in the central nervous system. Mol. Cell. Biol. 23, 1044-1053 (2003) (Pubitemid 36133520)
90. I. D. Tonks, E. Hacker, N. Irwin, H. K. Muller, P. Keith, A. Mould, A. Zournazi, S. Pavey, N. K. Hayward, G. Walker, and G. F. Kay: Melanocytes in conditional Rb-/-mice are normal in vivo but exhibit proliferation and pigmentation defects in vitro. Pigment Cell Research 18, 252-264 (2005) (Pubitemid 41032885)
91. M. Vooijs, M. van der Valk, H. te Riele, and A. Berns: Flp-mediated tissue-specific inactivation of the retinoblastoma tumor suppressor gene in the mouse. Oncogene 17, 1-12 (1998) (Pubitemid 28360523)
92. E. C. R. Maandag, M. Vandervalk, M. Vlaar, C. Feltkamp, J. Obrien, M. Vanroon, N. Vanderlugt, A. Berns, and H. Teriele: Developmental Rescue of An Embryonic-Lethal Mutation in the Retinoblastoma Gene in Chimeric Mice. EMBO J. 13, 4260-4268 (1994) (Pubitemid 24295198)
93. B. O. Williams, E. M. Schmitt, L. Remington, R. T. Bronson, D. M. Albert, R. A. Weinberg, and T. Jacks: Extensive Contribution of Rb-Deficient Cells to Adult Chimeric Mice with Limited Histopathological Consequences. EMBO J. 13, 4251-4259 (1994) (Pubitemid 24295197)
94. M. M. Lipinski, K. F. Macleod, B. O. Williams, T. L. Mullaney, D. Crowley, and T. Jacks: Cell-autonomous and non-cell-autonomous functions of the Rb tumor suppressor in developing central nervous system. EMBO J. 20, 3402-3413 (2001) (Pubitemid 32634348)
95. K. L. Ferguson, J. L. Vanderluit, J. M. Hebert, W. C. McIntosh, E. Tibbo, J. G. MacLaurin, D. S. Park, V. A. Wallace, M. Vooijs, S. K. McConnell, and R. S. Slack: Telencephalon-specific Rb knockouts reveal enhanced neurogenesis, survival and abnormal cortical development. EMBO J. 21, 3337-3346 (2002) (Pubitemid 34760566)
96. A. de Bruin, L. Z. Wu, H. I. Saavedra, P. Wilson, Y. Yang, T. J. Rosol, M. Weinstein, M. L. Robinson, and G. Leone: Rb function in extraembryonic lineages suppresses apoptosis in the CNS of Rb-deficient mice. Proc. Natl. Acad. Sci. U. S. A. 100, 6546-6551 (2003) (Pubitemid 36666618)
97. B. T. Spike, A. Dirlam, B. C. Dibling, J. Marvin, B. O. Williams, T. Jacks, and K. F. Macleod: The Rb tumor suppressor is required for stress erythropoiesis. EMBO J. 23, 4319-4329 (2004) (Pubitemid 39546169)
98. E. Zacksenhaus, Z. Jiang, D. Chung, J. D. Marth, R. A. Phillips, and B. L. Gallie: pRb controls proliferation, differentiation, and death of skeletal muscle cells and other lineages during embryogenesis. Genes Dev. 10, 3051-3064 (1996) (Pubitemid 26412531)
99. G. Camarda, F. Siepi, D. Pajalunga, C. Bernardini, R. Rossi, A. Montecucco, E. Meccia, and M. Crescenzi: A pRb-independent mechanism preserves the postmitotic state in terminally differentiated skeletal muscle cells. J. Cell. Biol. 167, 417-423 (2004) (Pubitemid 39489050)
100. M. S. Hub, M. H. Parker, A. Scime, R. Parks, and M. A. Rudnicki: Rb is required for progression through myogenic differentiation but not maintenance of terminal differentiation. J. Cell. Biol. 166, 865-876 (2004) (Pubitemid 39249837)
101. E. Robanus-Maandag, M. Dekker, M. van der Valk, M. L. Carrozza, J. C. Jeanny, J. H. Dannenberg, A. Berns, and H. T. Riele: p107 is a suppressor of retinoblastoma development in pRb-deficient mice. Genes Dev. 12, 1599-1609 (1998) (Pubitemid 28299512)
102. D. Chen, I. Livne-Bar, J. L. Vanderluit, R. S. Slack, M. Agochiya, and R. Bremner: Cell-specific effects of RB or RB/p107 loss on retinal development implicate an intrinsically death-resistant cell-of-origin in retinoblastoma. Cancer Cell 5, 539-551 (2004) (Pubitemid 38748916)
103. J. K. Zhang, B. Schweers, and M. A. Dyer: The first knockout mouse model of retinoblastoma. Cell Cycle 3, 952-959 (2004) (Pubitemid 40185382)
104. D. MacPherson, J. Sage, T. Kim, D. Ho, M. E. McLaughlin, and T. Jacks: Cell type-specific effects of Rb deletion in the murine retina. Genes Dev. 18, 1681-1694 (2004) (Pubitemid 38938185)
105. M. A. Dyer, B. Schweers, J. Gray, and J. Zhang: Compensation by p107 following Rb gene inactivation prevents retinoblastoma in mice but not humans. Investigative Ophthalmology & Visual Science 46 (2005)
106. S. L. Donovan, B. Schweers, R. Martins, D. Johnson, and M. A. Dyer: Compensation by tumor suppressor genes during retinal development in mice and humans. Bmc Biology 4 (2006)
107. X. Q. Tan, S. J. Martin, D. R. Green, and J. Y. J. Wang: Degradation of retinoblastoma protein in tumor necrosis factor-and CD95-induced cell death. J. Biol. Chem. 272, 9613-9616 (1997) (Pubitemid 27171617)
108. B. N. Chau, H. L. Borges, T. T. Chen, A. Masselli, I. C. Hunton, and Y. J. Y. Wang: Signal-dependent protection from apoptosis in mice expressing caspaseresistant Rb. Nat. Cell Biol. 4, 757-765 (2002) (Pubitemid 35214769)
109. H. L. Borges, J. Bird, K. Wasson, R. D. Cardiff, N. Varki, L. Eckmann, and J. Y. J. Wang: Tumor promotion by caspase-resistant retinoblastoma protein. Proc. Natl. Acad. Sci. U. S. A. 102, 15587-15592 (2005) (Pubitemid 41528100)
110. H. F. Sun, Y. J. Chang, B. Schweers, M. A. Dyer, X. J. Zhang, S. W. Hayward, and D. W. Goodrich: An E2F binding-deficient Rb1 protein partially rescues developmental defects associated with Rb1 nullizygosity. Mol. Cell. Biol. 26, 1527-1537 (2006) (Pubitemid 43202576)
111. E. J. Morris and N. N. Dyson: Retinoblastoma protein partners. Advances in Cancer Research, Vol 82 82, 1-54 (2001) (Pubitemid 32613381)
112. C. E. Isaac, S. M. Francis, A. L. Martens, L. M. Julian, L. A. Seifried, N. Erdmann, U. K. Binne, L. Harrington, P. Sicinski, N. G. Berube, N. J. Dyson, and F. A. Dick: The retinoblastoma protein regulates pericentric heterochromatin. Mol. Cell. Biol. 26, 3659-3671 (2006)
113. J. E. LeCouter, B. Kablar, W. R. Hardy, C. Y. Ying, L. A. Megeney, L. L. May, and M. A. Rudnicki: Straindependent myeloid hyperplasia, growth deficiency, and accelerated cell cycle in mice lacking the Rb-related p107 gene. Mol. Cell. Biol. 18, 7455-7465 (1998) (Pubitemid 28533064)
114. J. E. LeCouter, B. Kablar, P. F. M. Whyte, C. Y. Ying, and M. A. Rudnicki: Strain-dependent embryonic lethality in mice lacking the retinoblastoma-related p130 gene. Development 125, 4669-4679 (1998) (Pubitemid 29027197)
115. F. Rossi, H. E. MacLean, W. Yuan, R. O. Francis, E. Semenova, C. S. Lin, H. M. Kronenberg, and D. Cobrinik: p107 and p130 coordinately regulate proliferation, Cbfa1 expression, and hypertrophic differentiation during endochondral bone development. Dev. Biol. 247, 271-285 (2002) (Pubitemid 34734864)
116. A. Scime, G. Grenier, M. S. Huh, M. A. Gillespie, L. Bevilacqua, M. E. Harper, and M. A. Rudnicki: Rb and p107 regulate preadipocyte differentiation into white versus brown fat through repression of PGC-1 alpha. Cell Metab. 2, 283-295 (2005)
117. J. L. Vanderluit, K. L. Ferguson, V. Nikoletopoulou, M. Parker, V. Ruzhynsky, T. Alexson, S. M. McNamara, D. S. Park, M. Rudnicki, and R. S. Slack: p107 regulates neural precursor cells in the mammalian brain. J. Cell. Biol. 166, 853-863 (2004) (Pubitemid 39249836)
118. M. Malumbres and M. Barbacid: To cycle or not to cycle: A critical decision in cancer. Nature Reviews Cancer 1, 222-231 (2001) (Pubitemid 33741897)
119. D. J. Harrison, M. L. Hooper, J. F. Armstrong, and A. R. Clarke: Effects of Heterozygosity for the Rb-1 (T19Neo) Allele in the Mouse. Oncogene 10, 1615-1620 (1995)
120. M. L. Fero, M. Rivkin, M. Tasch, P. Porter, C. E. Carow, E. Firpo, K. Polyak, L. H. Tsai, V. Broudy, R. M. Perlmutter, K. Kaushansky, and J. M. Roberts: A syndrome of multiorgan hyperplasia with features of gigantism, tumorigenesis, and female sterility in p27 (Kip1)-deficient mice. Cell 85, 733-744 (1996)
121. H. Kiyokawa, R. D. Kineman, K. O. ManovaTodorova, V. C. Soares, E. S. Hoffman, M. Ono, D. Khanam, A. C. Hayday, L. A. Frohman, and A. Koff: Enhanced growth of mice lacking the cyclin-dependent kinase inhibitor function of p27 (Kip1). Cell 85, 721-732 (1996)
122. K. Nakayama, N. Ishida, M. Shirane, A. Inomata, T. Inoue, N. Shishido, I. Hori, D. Y. Loh, and K. Nakayama: Mice lacking p27 (Kip1) display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors. Cell 85, 707-720 (1996)
123. D. S. Franklin, V. L. Godfrey, H. Y. Lee, G. I. Kovalev, R. Schoonhoven, S. Chen-Kiang, L. S. Su, and Y. Xiong: CDK inhibitors p18 (INK4c) and p27 (Kip1) mediate two separate pathways to collaboratively suppress pituitary tumorigenesis. Genes Dev. 12, 2899-2911 (1998) (Pubitemid 28440148)
124. S. W. Leung, E. H. Wloga, A. F. Castro, T. Nguyen, R. T. Bronson, and L. Yamasaki: A dynamic switch in Rb+/-mediated neuroendocrine tumorigenesis. Oncogene 23, 3296-3307 (2004) (Pubitemid 38669819)
125. S. L. Asa and S. Ezzat: The pathogenesis of pituitary tumours. Nature Reviews Cancer 2, 836-849 (2002) (Pubitemid 37328902)
126. A. Y. Nikitin and W. H. Lee: Early loss of the retinoblastoma gene is associated with impaired growth inhibitory innervation during melanotroph carcinogenesis in Rb+/-mice. Genes Dev. 10, 1870-1879 (1996) (Pubitemid 26281682)
127. B. O. Williams, L. Remington, D. M. Albert, S. Mukai, R. T. Bronson, and T. Jacks: Cooperative Tumorigenic Effects of Germline Mutations in Rb and P53. Nat. Genet. 7, 480-484 (1994) (Pubitemid 24308333)
128. M. S. Park, J. Rosai, H. T. Nguyen, P. Capodieci, C. Cordon-Cardo, and A. Koff: p27 and Rb are on overlapping pathways suppressing tumorigenesis in mice. Proc. Natl. Acad. Sci. U. S. A. 96, 6382-6387 (1999) (Pubitemid 29256674)
129. S. W. Blain, H. I. Scher, C. Cordon-Cardo, and A. Koff: p27 as a target for cancer therapeutics. Cancer Cell 3, 111-115 (2003) (Pubitemid 37443384)
130. C. Carneiro, M. S. Jiao, M. Hu, D. Shaffer, M. Park, P. P. Pandolfi, C. Cordon-Cardo, and A. Koff: p27 deficiency desensitizes Rb-/-cells to signals that trigger apoptosis during pituitary tumor development. Oncogene 22, 361-369 (2003) (Pubitemid 36194332)
131. J. Brugarolas, R. T. Bronson, and T. Jacks: p21 Is a critical CDK2 regulator essential for proliferation control in Rb-deficient cells. J. Cell. Biol. 141, 503-514 (1998) (Pubitemid 28237097)
132. K. Y. Tsai, D. MacPherson, D. A. Rubinson, A. Y. Nikitin, R. Bronson, K. L. Mercer, D. Crowley, and T. Jacks: ARF mutation accelerates pituitary tumor development in Rb+/-mice. Proc. Natl. Acad. Sci. U. S. A. 99, 16865-16870 (2002) (Pubitemid 36034064)
133. M. A. Dyer and R. Bremner: The search for the retinoblastoma cell of origin. 5, 91-101 (2005)
134. L. Yamasaki, R. Bronson, B. O. Williams, N. J. Dyson, E. Harlow, and T. Jacks: Loss of E2F-1 reduces tumorigenesis and extends the lifespan of Rb1 (+/-) mice. Nat. Genet. 18, 360-364 (1998) (Pubitemid 28158165)
135. M. G. Paggi and A. Giordano: Who is the boss in the Retinoblastoma family? The point of view of Rb2/p130, the little brother. Cancer Res. 61, 4651-4654 (2001) (Pubitemid 32691869)
136. H. Stubdal, J. Zalvide, and J. A. DeCaprio: Simian virus 40 large T antigen alters the phosphorylation state of the RB-related proteins p130 and p107. J. Virol. 70, 2781-2788 (1996) (Pubitemid 26124275)
137. J. Zalvide and J. A. DeCaprio: Role of pRb-related proteins in simian virus 40 large-T-antigen-mediated transformation. Mol. Cell Biol. 15, 5800-5810 (1995)
138. K. A. Wikenheiser-Brokamp: Rb family proteins differentially regulate distinct cell lineages during epithelial development. Development 131, 4299-4310 (2004) (Pubitemid 39294527)
139. O. Casanovas, J. H. Hager, M. G. H. Chun, and D. Hanahan: Incomplete inhibition of the Rb tumor suppressor pathway in the context of inactivated p53 is sufficient for pancreatic islet tumorigenesis. Oncogene 24, 6597-6604 (2005) (Pubitemid 41486790)
140. M. Classon and N. Dyson: p107 and p130: Versatile proteins with interesting pockets. Exp. Cell Res. 264, 135-147 (2001) (Pubitemid 32989088)
141. J. H. Dannenberg, L. Schuijff, M. Dekker, M. van der Valk, and H. T. Riele: Tissue-specific tumor suppressor activity of retinoblastoma gene homologs p107 and p130. Genes Dev. 18, 2952-2962 (2004) (Pubitemid 39602313)
142. R. MacLellan, A. Garcia, M. Vooijs, P. Frenkel, M. Jordan, K. P. Roos, M. Fishbein, A. Berns, and M. F. Schneider: Cardiac-restricted targeting of the retinoblastoma gene reveals a role for Rb in terminal cardiac differentiation and apoptosis. Circulation 106, 315-315 (2002)
143. S. Marino, D. Hoogervoorst, S. Brandner, and A. Berns: Rb and p107 are required for normal cerebellar development and granule cell survival but not for Purkinje cell persistence. Development 130, 3359-3368 (2003) (Pubitemid 37010000)
144. S. Ruiz, M. Santos, C. Segrelles, H. Leis, J. L. Jorcano, A. Berns, J. M. Paramio, and M. Vooijs: Unique and overlapping functions of pRb and p107 in the control of proliferation and differentiation in epidermis. Development 131, 2737-2748 (2004) (Pubitemid 38877905)
145. S. J. Balsitis, J. Sage, S. Duensing, K. Munger, T. Jacks, and P. F. Lambert: Recapitulation of the effects of the human papillomavirus type 16 E7 oncogene on mouse epithelium by somatic Rb deletion and detection of pRbindependent effects of E7 in vivo. Mol. Cell Biol. 23, 9094-9103 (2003) (Pubitemid 37499799)
146. M. H. Kucherlapati, A. A. Nguyen, R. T. Bronson, and R. S. Kucherlapati: Inactivation of conditional Rb by Villin-Cre leads to aggressive tumors outside the gastrointestinal tract. Cancer Res. 66, 3576-3583 (2006)
147. C. Sage, M. Q. Huang, K. Karimi, G. Gutierrez, M. A. Vollrath, D. S. Zhang, J. Garcia-Anoveros, P. W. Hinds, J. T. Corwin, D. P. Corey, and Z. Y. Chen: Proliferation of functional hair cells in vivo in the absence of the retinoblastoma protein. Science 307, 1114-1118 (2005) (Pubitemid 40262118)
148. C. N. Mayhew, E. E. Bosco, S. R. Fox, T. Okaya, P. Tarapore, S. J. Schwemberger, G. F. Babcock, A. B. Lentsch, K. Fukasawa, and E. S. Knudsen: Liver-specific pRB loss results in ectopic cell cycle entry and aberrant ploidy. Cancer Res. 65, 4568-4577 (2005) (Pubitemid 40740792)
149. R. Meuwissen, S. C. Linn, R. I. Linnoila, J. Zevenhoven, W. J. Mooi, and A. Berns: Induction of small cell lung cancer by somatic inactivation of both Trp53 and Rb1 in a conditional mouse model. Cancer Cell 4, 181-189 (2003) (Pubitemid 37163832)
150. A. Flesken-Nikitin, K. C. Choi, J. P. Eng, E. N. Shmidt, and A. Y. Nikitin: Induction of carcinogenesis by concurrent inactivation of p53 and Rb1 in the mouse ovarian surface epithelium. Cancer Res. 63, 3459-3463 (2003) (Pubitemid 36793020)
151. L. A. Maddison, B. W. Sutherland, R. J. Barrios, and N. M. Greenberg: Conditional deletion of Rb causes early stage prostate cancer. 64, 6018-6025 (2004)
152. S. L. Donovan and M. A. Dyer: Developmental defects in Rb-deficient retinae. Vision Research 44, 3323-3333 (2004) (Pubitemid 39469302)
153. J. K. Zhang, J. Gray, L. Z. Wu, G. Leone, S. Rowan, C. L. Cepko, X. M. Zhu, C. M. Craft, and M. A. Dyer: Rb regulates proliferation and rod photoreceptor development in the mouse retina. Nature Genetics 36, 351-360 (2004) (Pubitemid 38437257)
154. M. Vooijs, H. te Riele, M. van der Valk, and A. Berns: Tumor formation in mice with somatic inactivation of the retinoblastoma gene in interphotoreceptor retinol binding protein-expressing cells. Oncogene 21, 4635-4645 (2002) (Pubitemid 34833141)
155. U. Ziebold, T. Reza, A. Caron, and J. A. Lees: E2F3 contributes both to the inappropriate proliferation and to the apoptosis arising in Rb mutant embryos. Genes Dev. 15, 386-391 (2001) (Pubitemid 32186999)